Protagen AG - Product Pipeline Analysis, 2020 Update



Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic lupus erythematosus, systemic sclerosis, multiple sclerosis and ankylosing spondylitis. Protagen’s technology comprise SeroTag, which enables differential diagnosis and patient stratification in various diseases. The company also develops companion diagnostics to pharmaceutical and biotechnology companies. The company partners with various educational organization and other healthcare companies. It markets its products through its network of distributors. Protagen is headquartered in Dortmund, Nordrhein-Westfalen, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Protagen AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




Protagen AG Company Overview
Protagen AG Company Snapshot
Protagen AG Pipeline Products and Ongoing Clinical Trials Overview
Protagen AG – Pipeline Analysis Overview
Protagen AG - Key Facts
Protagen AG - Major Products and Services
Protagen AG Pipeline Products by Development Stage
Protagen AG Pipeline Products Overview
Diagnostic Assay - Alzheimers Disease
Diagnostic Assay - Alzheimers Disease Product Overview
Diagnostic Assay - Ankylosing Spondylitis
Diagnostic Assay - Ankylosing Spondylitis Product Overview
Diagnostic Assay - Breast Cancer
Diagnostic Assay - Breast Cancer Product Overview
Diagnostic Assay - Colon Cancer
Diagnostic Assay - Colon Cancer Product Overview
Diagnostic Assay - Juvenile Idiopathic Arthritis
Diagnostic Assay - Juvenile Idiopathic Arthritis Product Overview
Diagnostic Assay - Multiple Sclerosis
Diagnostic Assay - Multiple Sclerosis Product Overview
Diagnostic Assay - Neuromyelitis Optica
Diagnostic Assay - Neuromyelitis Optica Product Overview
Diagnostic Assay - Ovarian Cancer
Diagnostic Assay - Ovarian Cancer Product Overview
Diagnostic Assay - Pancreatic Cancer
Diagnostic Assay - Pancreatic Cancer Product Overview
Diagnostic Assay - Parkinsons Disease
Diagnostic Assay - Parkinsons Disease Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Assay - Type 1 Diabetes
Diagnostic Assay - Type 1 Diabetes Product Overview
Multilisa SLE
Multilisa SLE Product Overview
Multiplex Assay - Autoimmune Disease
Multiplex Assay - Autoimmune Disease Product Overview
Multiplex Assay - Cancer
Multiplex Assay - Cancer Product Overview
NavigAID - Cancer
NavigAID - Cancer Product Overview
NavigAID - Rheumatoid Arthritis
NavigAID - Rheumatoid Arthritis Product Overview
NavigAID - Sjogren’s Syndrome
NavigAID - Sjogren’s Syndrome Product Overview
Protagen Diagnostic Assay - Endometriosis
Protagen Diagnostic Assay - Endometriosis Product Overview
Protagen AG - Key Competitors
Protagen AG - Key Employees
Protagen AG - Locations And Subsidiaries
Head Office
Recent Developments
Protagen AG, Recent Developments
Dec 18, 2018: Protagen names Dr. Jessica Hassel to its Scientific Advisory Board
Apr 10, 2018: Gustave Roussy and Protagen Collaborate to Improve the Risk Profiling of Cancer Patients Undergoing Immunotherapy
Feb 02, 2017: Protagen join forces with the U.S. National Cancer Institute to answer pressing questions in immuno-oncology
Dec 15, 2016: PROTAGEN launches NavigAID assay to support clinical drug development for autoimmune diseases
Dec 13, 2016: PROTAGEN Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases
Jul 20, 2016: Protagen Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member
Jun 15, 2016: Protagen announces CE Mark for its proprietary Multilisa BICD2 test for better diagnosis of Systemic Sclerosis
May 31, 2016: Protagen launches first CE marked diagnostic assay Multilisa Scl-70 for the diagnosis of Systemic Sclerosis
May 31, 2016: Protagen Launches First CE Marked Diagnostic Assay Multilisa CENP-B For The Diagnosis Of Systemic Sclerosis
Feb 11, 2016: Protagen supports novel route to serum based Prostate Cancer Diagnostics
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer


List Of Tables


Protagen AG Pipeline Products and Ongoing Clinical Trials Overview
Protagen AG Pipeline Products by Equipment Type
Protagen AG Pipeline Products by Indication
Protagen AG, Key Facts
Protagen AG, Major Products and Services
Protagen AG Number of Pipeline Products by Development Stage
Protagen AG Pipeline Products Summary by Development Stage
Diagnostic Assay - Alzheimers Disease - Product Status
Diagnostic Assay - Alzheimers Disease - Product Description
Diagnostic Assay - Ankylosing Spondylitis - Product Status
Diagnostic Assay - Ankylosing Spondylitis - Product Description
Diagnostic Assay - Breast Cancer - Product Status
Diagnostic Assay - Breast Cancer - Product Description
Diagnostic Assay - Colon Cancer - Product Status
Diagnostic Assay - Colon Cancer - Product Description
Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Status
Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Description
Diagnostic Assay - Multiple Sclerosis - Product Status
Diagnostic Assay - Multiple Sclerosis - Product Description
Diagnostic Assay - Neuromyelitis Optica - Product Status
Diagnostic Assay - Neuromyelitis Optica - Product Description
Diagnostic Assay - Ovarian Cancer - Product Status
Diagnostic Assay - Ovarian Cancer - Product Description
Diagnostic Assay - Pancreatic Cancer - Product Status
Diagnostic Assay - Pancreatic Cancer - Product Description
Diagnostic Assay - Parkinsons Disease - Product Status
Diagnostic Assay - Parkinsons Disease - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Assay - Type 1 Diabetes - Product Status
Diagnostic Assay - Type 1 Diabetes - Product Description
Multilisa SLE - Product Status
Multilisa SLE - Product Description
Multiplex Assay - Autoimmune Disease - Product Status
Multiplex Assay - Autoimmune Disease - Product Description
Multiplex Assay - Cancer - Product Status
Multiplex Assay - Cancer - Product Description
NavigAID - Cancer - Product Status
NavigAID - Cancer - Product Description
NavigAID - Rheumatoid Arthritis - Product Status
NavigAID - Rheumatoid Arthritis - Product Description
NavigAID - Sjogren’s Syndrome - Product Status
NavigAID - Sjogren’s Syndrome - Product Description
Protagen Diagnostic Assay - Endometriosis - Product Status
Protagen Diagnostic Assay - Endometriosis - Product Description
Protagen AG, Key Employees
Glossary


List Of Figures


Protagen AG Pipeline Products by Equipment Type
Protagen AG Pipeline Products by Development Stage


Protagen AG - Medical Equipment - Deals and Alliances Profile.

Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The companys products include multilisa Ssc, multilisa SLE and multilisa RA. It provides

USD 250 View Report

Protagen AG - Product Pipeline Analysis, 2017 Update

Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The companys products include multilisa Ssc, multilisa SLE and multilisa RA. It provides

USD 750 View Report

Benteler International AG - Strategy, SWOT and Corporate Finance Report

Benteler International AG - Strategy, SWOT and Corporate Finance ReportBenteler International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

RUAG International Holding AG - Strategy, SWOT and Corporate Finance Report

RUAG International Holding AG - Strategy, SWOT and Corporate Finance ReportRUAG International Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available